BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
Trial ID or NCT#
Status
Purpose
A prospective, multinational, randomized, double-blind, clinical trial evaluating the safety and effectiveness of a novel atrioventricular interval modulation (AVIM) algorithm downloaded into a dual-chamber Medtronic Astra/Azure pacemaker.
Official Title
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
Investigator(s)
Contact us to find out if this trial is right for you.
Contact
Hans-Peter Stoll, MD, PhD
646-956-2161
View on